To this end, it is incumbent upon you to contact a Primary Pulmonary Hypertension Attorney who specializes in the field of pharmacology litigation, and who is caring and supportive to ensure you receive appropriate compensation.



When contacting a Primary Pulmonary Hypertension Attorney, the first thing you want to ensure is that they are knowledgeable in the area. You must find one who has the most competent attorneys who have litigated on behalf of clients who have taken Fen-Phen, and have been attorneys-of-record in cases involving Primary Pulmonary Hypertension.

The first priority of the attorneys and staff is serving each client's unique legal needs with the highest level of integrity and professional competence.

Now, you may say, "Well I have seen a variety of online lawyers who claim to be the best in pharmaceutical litigation." You must research the best one, know this horrible disease, and know full well the emotional and financial impact this disease can have on a family.

Find an attorney's website that is filled with information concerning Primary Pulmonary Hypertension as well as a plethora of information on their Practice Areas page which gives you tremendous insight into the type of cases they have handled and the lengths to which they will go to serve their client.

Primary Pulmonary Hypertension is a deadly disease, and any individual who has this disease deserves a lawyer who is most knowledgeable in PPH cases as well as the disease itself.

Here is a sample of a discussion on the use of dietary supplements as it relates to the drug Fen-Phen:

The use of dietary supplements that contain ephedra alkaloids may pose a health risk to some persons. Dietary supplements that contain ephedra alkaloids (sometimes called ma huang) are widely promoted and used in the United States as a means of losing weight and increasing energy.

In the light of recently reported adverse events related to use of these products, the Food and Drug Administration (FDA) has proposed limits on the dose and duration of use of such supplements. The FDA requested an independent review of reports of adverse events related to the use of supplements that contained ephedra alkaloids to assess causation and to estimate the level of risk the use of these supplements poses to consumers.

We reviewed 140 reports of adverse events related to the use of dietary supplements containing ephedra alkaloids that were submitted to the FDA between June 1, 1997, and March 31, 1999. A standardized rating system for assessing causation was applied to each adverse event.

Thirty-one percent of cases were considered to be definitely or probably related to the use of supplements containing ephedra alkaloids, and 31 percent were deemed to be possibly related. Among the adverse events that were deemed definitely, probably, or possibly related to the use of supplements containing ephedra alkaloids:

47 percent involved cardiovascular symptoms

18 percent involved the central nervous system.

Hypertension was the single most frequent adverse effect (17 reports), followed by palpitations, tachycardia, or both (13); stroke (10); and seizures (7) Ten events resulted in death, and 13 events produced permanent disability, representing 26 percent of the definite, probable, and possible cases.

There is no doubt from the above discussion that you must be more aware of the affects of this drug and the fact that litigation is on-going.